// App-Quantinova.ai

e23283 : Potential of a novel technique for constructing tissue microarrays from core needle biopsy as seen in older women with primary breast cancer.

Researchers

Presenter

  • Mohammad A Albanghali

Principal Investigators

  • Emad Rakha

  • Andrew R. Green

  • Binafsha Manzoor Syed

  • Christopher Nolan

  • Maria Aranzazu Diez-Rodriguez

  • Ian O. Ellis

  • Kwok-Leung Cheung

Medical Centers

  • School of Medicine, University of Nottingham, Nottingham, United Kingdom

  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom

  • Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham, United Kingdom

  • Liaquat University of Medical and Health Sciences, Hyderabad, Pakistan

  • Division of Pathology, Nottingham University Hospitals, Nottingham, United Kingdom

  • Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham, Royal Derby Hospital Centre, Derby, United Kingdom

Locations

  • United Kingdom

  • Pakistan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final